Targeted delivery of immunomodulatory proteins: evaluation of novel antibody-chemokine and antibody-cytokine fusion proteins for cancer therapy
Open access
Author
Date
2015Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010414738Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH-ZürichSubject
HYBRIDPROTEINE + REKOMBINANTE PROTEINE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ZYTOKINE (IMMUNOLOGIE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); HYBRID PROTEINS + RECOMBINANT PROTEINS; TARGETED DRUGS (PHARMACOLOGY); ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); CYTOKINES (IMMUNOLOGY); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03463 - Neri, Dario (ehemalig) / Neri, Dario (former)
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 22338.More
Show all metadata
ETH Bibliography
yes
Altmetrics